SCHEMBL38785

SCHEMBL38785

C[C@@H]1CCCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL857124 1.00
SCHEMBL22708 1.00
Water SCHEMBL28084183 0.97
Cyclohexanone SCHEMBL28845315 0.93 ALDH1A1 (0.50)
SCHEMBL14066006 0.92
SCHEMBL105656 0.92
SCHEMBL9490715 0.91 TRIM24 (0.38)
SCHEMBL24304032 0.90 KMT2A (0.54)
SCHEMBL2196645 0.90 KMT2A (0.54)
SCHEMBL230871 0.90 KMT2A (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114317624-B Method for synthesizing poly- (R) -5-methyl-epsilon-caprolactone by utilizing micro-channel reaction device through three-enzyme catalysis 南京工业大学 2024-05-07 CN claimed
CN-114317624-A Method for synthesizing poly- (R) -5-methyl-epsilon-caprolactone by three-enzyme catalysis by using microchannel reaction device 南京工业大学 2022-04-12 CN claimed
EP-1015415-B1 NOVEL STEREOSELECTIVE PROCESSES FOR THE PREPARATION OF GABAPENTIN ANALOGUES WARNER LAMBERT CO (US) 2003-05-07 EP claimed
JP-8245668-A None JP disclosed
US-20260043010-A1 ENONE REDUCTASES CODEXIS, INC. (US) 2026-02-12 US disclosed
US-12371674-B2 Enone reductases CODEXIS, INC. (US) 2025-07-29 US disclosed
US-20250171431-A1 HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE HORIZON THERAPEUTICS IRELAND DAC (IE) 2025-05-29 US disclosed
WO-2025030163-A1 HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE HORIZON THERAPEUTICS IRELAND DAC (IE) 2025-02-06 WO disclosed
US-20240218002-A1 PHOSPHINE-UREA LIGANDS FOR TRANSITION METAL CATALYZED CROSS-COUPLING REACTIONS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2024-07-04 US disclosed
CN-114317624-B Method for synthesizing poly- (R) -5-methyl-epsilon-caprolactone by utilizing micro-channel reaction device through three-enzyme catalysis 南京工业大学 2024-05-07 CN disclosed
WO-2023250316-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed
US-5162586-A Catalyst complex containing copper, a disubstituted aminetroponeimine chelating ligand and an organometallic reagent MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1992-11-10 US disclosed
EP-0479970-A1 ANTIMALARIAL ANALOGS OF ARTEMISININ SRI INTERNATIONAL (US) 1992-04-15 EP disclosed
WO-1991014689-A1 ANTIMALARIAL ANALOGS OF ARTEMISININ SRI INTERNATIONAL (US) 1991-10-03 WO disclosed
US-4962214-A COPPER AMINOTROPONEIMINE COMPLEX CATALYSTS MASSACHUSETTES INSTITUTE OF TECHNOLOGY (US) 1990-10-09 US disclosed
WO-1989010916-A1 ENANTIOSELECTIVE ADDITION OF HYDROCARBONS TO ALPHA,BETA-UNSATURATED CARBONYL COMPOUNDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-11-16 WO disclosed
WO-1989009209-A1 PIPERIDINE RING MODIFIED PHENCYCLIDINE ANALOGS AS ANTICONVULSANTS MARION LABORATORIES, INC. (US) 1989-10-05 WO disclosed
EP-0067517-B1 PROCESS FOR THE PREPARATION OF AN ENANTIOMER OF A BETA-LACTAM DERIVATIVE BEECHAM GROUP PLC (GB) 1986-02-26 EP disclosed
US-4443599-A 8-Oxo-3-oxa-1-azabicyclo[4.2.0]octanes containing a chiral center BEECHAM GROUP P.L.C. (GB) 1984-04-17 US disclosed
EP-0067517-A1 Process for the preparation of an enantiomer of a beta-lactam derivative BEECHAM GROUP PLC (GB) 1982-12-22 EP disclosed